Peptides that ellicit T cellular immunity

The invention relates to peptides from cancer related protein products of frameshift mutated genes, said protein products eliciting T cellular immunity, for use in cancer vaccines and compositions for anticancer treatment. In particular the invention relates to protein products of frameshift mutated...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	GAUDERNACK, GUSTAV, MOELLER, MONA, SAETERDAL, INGVIL, GJERTSEN, MARIANNE KLEMP, ERIKSEN, JON AMUND
Format:	Patent
Sprache:	eng ; fre ; ger
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PHYSICS PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS TESTING VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The invention relates to peptides from cancer related protein products of frameshift mutated genes, said protein products eliciting T cellular immunity, for use in cancer vaccines and compositions for anticancer treatment. In particular the invention relates to protein products of frameshift mutated BAX or TGF²RII genes.